RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancer
Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) still present a huge threaten to women ’s health, especially the local advanced patients. Hence, developing more effectiveness prognostic ...
Source: Cancer Cell International - Category: Cancer & Oncology Authors: Xiaomei Chen, Xunhu Dong, Hong Li, Tingting Wu, Haoyin Liu, Jie Wu, Wei Ge, Lingji Hao and Zhe Zhang Tags: Research Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Chemotherapy | Immunotherapy | Skin Cancer | Squamous Cell Carcinoma | Women